CAXTON ASSOCIATES LP - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 128 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.7%.

Quarter-by-quarter ownership
CAXTON ASSOCIATES LP ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q1 2022$426,000
-25.7%
325,5380.0%0.04%
-39.7%
Q4 2021$573,000
+111.4%
325,538
+160.7%
0.06%
+93.3%
Q3 2021$271,000
+173.7%
124,850
+342.4%
0.03%
+172.7%
Q2 2021$99,000
-61.9%
28,222
+6.2%
0.01%
-77.1%
Q1 2020$260,00026,5700.05%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q1 2020
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 4,112,355$40,178,00034.81%
Versant Venture Management, LLC 7,068,233$69,056,636,00018.94%
ACUTA CAPITAL PARTNERS, LLC 1,704,500$16,653,0008.07%
Soleus Capital Management, L.P. 313,900$3,067,0003.57%
Ghost Tree Capital, LLC 1,305,500$12,755,0003.38%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$4,690,0002.97%
RTW INVESTMENTS, LP 6,631,627$64,791,0002.79%
VR Adviser, LLC 994,381$9,715,0002.63%
Avoro Capital Advisors LLC 7,150,000$69,856,0002.36%
RA Capital Management 7,272,714$71,054,0002.24%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders